VYNE Therapeutics has distributed its previously announced special cash dividend to stockholders of record as of July 22, 2026, with the payment made on July 23. The company also confirmed that its 1-for-50 reverse stock split is expected to take effect on July 24, after which shares will begin trading on a post-split basis on Nasdaq under a new CUSIP on July 27. The closing of the proposed merger with Yarrow Bioscience, originally anticipated around July 24, is now expected early in the week of July 27, pending final Nasdaq listing approval. Following the merger, the combined company will trade under the name Yarrow Bioscience and the ticker YARW. Due to the dividend exceeding 25% of the stock price at declaration, Nasdaq set the ex-dividend date as July 24, and trades during the due bill period from July 21 through July 23 carry an obligation for sellers to deliver the dividend to buyers.
Yarrow Bioscience IncCompany distributes special cash dividend and executes reverse stock split, both capital events; merger with Yarrow Bioscience is pending.
Yarrow Bioscience is the merger partner; combined company will trade under YARW ticker, pending Nasdaq approval.